ICL670 + Chelation + No chelation
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Aplastic Anemia
Conditions
Aplastic Anemia
Trial Timeline
Jun 23, 2014 → Oct 17, 2016
NCT ID
NCT01818726About ICL670 + Chelation + No chelation
ICL670 + Chelation + No chelation is a approved stage product being developed by Novartis for Aplastic Anemia. The current trial status is terminated. This product is registered under clinical trial identifier NCT01818726. Target conditions include Aplastic Anemia.
What happened to similar drugs?
0 of 6 similar drugs in Aplastic Anemia were approved
Approved (0) Terminated (1) Active (5)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01818726 | Approved | Terminated |
Competing Products
20 competing products in Aplastic Anemia